MediciNova (MNOV) Announces Results From a Phase II/III Interstitial Cystitis Trial With MN-001
Tweet Send to a Friend
MediciNova (NASDAQ: MNOV) and the Hercules Market of the Osaka Securities Exchange announced the results from its Phase II/III randomized ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


